The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Abstract
Molecular chaperones, ubiquitin ligases and proteasome impairment have been implicated in several neurodegenerative diseases, including Alzheimer's and Parkinson's disease, which are characterized by accumulation of abnormal protein aggregates (e.g. tau and alpha-synuclein respectively). Here we report that CHIP, an ubiquitin ligase that interacts directly with Hsp70/90, induces ubiquitination of the microtubule associated protein, tau. CHIP also increases tau aggregation. Consistent with this observation, diverse of tau lesions in human postmortem tissue were found to be immunopositive for CHIP. Conversely, induction of Hsp70 through treatment with either geldanamycin or heat shock factor 1 leads to a decrease in tau steady-state levels and a selective reduction in detergent insoluble tau. Furthermore, 30-month-old mice overexpressing inducible Hsp70 show a significant reduction in tau levels. Together these data demonstrate that the Hsp70/CHIP chaperone system plays an important role in the regulation of tau turnover and the selective elimination of abnormal tau species. Hsp70/CHIP may therefore play an important role in the pathogenesis of tauopathies and also represents a potential therapeutic target.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Induction of Hsp70 by geldanamycin promotes tau degradation both in vitro and in vivo, whereas deletion of CHIP increases the accumulation of phosphorylated tau and caspase-3 cleaved tau [167, 171].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [167]
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Zou, J., Guo, Y., Guettouche, T., Smith, D. F., & Voellmy, R. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81588-3 · Cited by 1,232
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 719
Heat Shock Proteins and Endoplasmic Reticulum Stress
Raghunath, A., Panneerselvam, L., Sundarraj, K., & Perumal, E. (2018) · Heat shock proteins · doi:10.1007/978-3-319-90725-3_3 · Cited by 12
Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1
Akber, U., Jo, H., Jeon, S., Yang, S., Bong, S., Lim, S., Kim, Y. K., Park, Z., & Park, C. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2494-20.2021 · Cited by 14
Singh, R. J., Hussain, J., Kaur, A., Jamdare, B. G., Pathak, D., Garg, K., Kaur, R., Shankar, S., & Sunkaria, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102002 · Cited by 14
Hsp70 clears misfolded kinases that partitioned into distinct quality-control compartments
Roy, J., Mitra, S., Sengupta, K., & Mandal, A. K. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-08-1262 · Cited by 12
Varghese, M., Santa‐María, I., Ho, L., Ward, L. M., Yemul, S., Dubner, L., Ksiȩżak-Reding, H., & Pasinetti, G. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160166 · Cited by 14
Depletion of oxidative and endoplasmic reticulum stress regulators in Pick disease
Ilieva, E. V., Naudí, A., Kichev, A., Ferrer, I., Pamplona, R., & Portero‐Otín, M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.006 · Cited by 13
Romero‐Fernandez, W., Carvajal‐Tapia, C., Prusky, A., Katdare, K. A., Wang, E., Shostak, A., Ventura‐Antunes, L., Harmsen, H. J., Lippmann, E. S., Fuxé, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38000-4 · Cited by 11
Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
Majumder, M., & Dutta, D. (2024) · Cells · doi:10.3390/cells13131112 · Cited by 14
Class II HDACs and Neuronal Regeneration
Tang, B. L. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24802 · Cited by 13
Guerrero, R., Navarro, P., Gallego, E., García-Cabrero, A. M., Ávila, J., & Sánchez, M. P. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0470-3 · Cited by 12
Lonati, E., Sala, G., Tresoldi, V., Coco, S., Salerno, D., Milani, C., Losurdo, M., Farina, F., Botto, L., Ferrarese, C., et al. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1199-7 · Cited by 12
Babizhayev, M. A., Nikolayev, G. M., Nikolayeva, J. G., & Yegorov, Y. E. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181e71fb7 · Cited by 12
Cao, F., Wang, Y., Peng, B., Zhang, X., Zhang, D., & Xu, L. (2017) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1633 · Cited by 12
Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13
Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/393510 · Cited by 11
HSP70 interacts with Rheb, inhibiting mTORC1 signaling
Ryu, H., & Ha, S. H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.053 · Cited by 11
Hu, N., Hu, Z., Ondrejčák, T., Yu, P., Zhang, Y., Yang, Y., Klyubin, I. V., Kennelly, S., & Rowan, M. J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360166 · Cited by 11
Li, G., Xiao, K., Li, Y., Gao, J., He, S., & Li, T. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00899-2 · Cited by 11
Kraemer, B. C., & Schellenberg, G. D. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77007-6 · Cited by 11
Fighting the Cause of Alzheimer’s and GNE Myopathy
Devi, S., Yadav, R., Chanana, P., & Arya, R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00669 · Cited by 12
Navarro, P., Guerrero, R., Gallego, E., Ávila, J., Luquín, M. R., Ruiz, P., & Sánchez, M. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.01.017 · Cited by 11
Sun, K. T., & Mok, S. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00512 · Cited by 12
Kanack, A. J., Olp, M. D., Newsom, O. J., Scaglione, J. B., Gooden, D. M., McMahon, K., Smith, B. C., & Scaglione, K. M. (2022) · ChemBioChem · doi:10.1002/cbic.202100633 · Cited by 11
Activation of Heat Shock Proteins by Nanocurcumin to Prevent Neurodegenerative Diseases
Manna, J. (2014) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000139 · Cited by 10
Carlomagno, Y., Chung, D. C., Yue, M., Kurti, A., Avendano, N. M., Castanedes‐Casey, M., Hinkle, K. M., Jansen‐West, K. R., Daughrity, L. M., Tong, J., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0661-2 · Cited by 10
Self-citationA General in Vitro Assay for Studying Enzymatic Activities of the Ubiquitin System
Zuo, Y., Chong, B. K., Jiang, K., Finley, D. J., Klenerman, D., & Ye, Y. (2020) · Biochemistry · doi:10.1021/acs.biochem.9b00602 · Cited by 10
The Interplay Between Proteostasis Systems and Parkinson’s Disease
Lázaro, D. F., & Outeiro, T. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_9 · Cited by 10
Benzothiazole Substitution Analogs of Rhodacyanine Hsp70 Inhibitors Modulate Tau Accumulation
Hill, S. E., Beaulieu‐Abdelahad, D., Lemus, A., Webster, J. M., Ospina, S. R., Darling, A. L., Martin, M. D., Patel, S., Bridenstine, L., Swonger, R., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00919 · Cited by 9
Mitra, G., Gupta, S., Poddar, A., & Bhattacharyya, B. (2015) · Biophysical Chemistry · doi:10.1016/j.bpc.2015.06.003 · Cited by 11
Sordu, P., Alaylıoğlu, M., Samancı, B., Bulu, E., Güleç, Z. E. K., Bılgıç, B., Hanagasi, H. A., Gurvit, H. I., Ulutin, T., Dursun, E., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251329540 · Cited by 9
Discovery of Small-Molecule Ligands for the E3 Ligase STUB1/CHIP from a DNA-Encoded Library Screen
Lucas, S. C. C., Milbradt, A. G., Breed, J., Genst, E. D., Jackson, A., Solovyeva, A., Ackroyd, B., Bauer, M. R., Liu, J., Longmire, D., et al. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00361 · Cited by 9
Han, M., Saxton, A. D., Currey, H. N., Waldherr, S. M., Liachko, N. F., & Kraemer, B. C. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050473 · Cited by 9
Pin1: A New Outlook in Alzheimers Disease
Lonati, E., Masserini, M., & Bulbarelli, A. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717140 · Cited by 9
Dynamics of microtubules and their associated proteins
Benarroch, E. E. (2016) · Neurology · doi:10.1212/wnl.0000000000002686 · Cited by 9
Yeast prions, mammalian amyloidoses, and the problem of proteomic networks
Galkin, A. P., Mironova, L. N., Zhouravleva, G. A., & Inge-Vechtomov, S. G. (2006) · Russian Journal of Genetics · doi:10.1134/s1022795406110135 · Cited by 9
Heat Shock Proteins and Protein Quality Control in Alzheimer’s Disease
van Leeuwen, F. W., & Kampinga, H. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00010-9 · Cited by 9
Elmatboly, A. M., Sherif, A., Deeb, D. A., Benmelouka, A. Y., Bin-Jumah, M. N., Aleya, L., & Abdel‐Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-07914-1 · Cited by 9
Checler, F., & Buée, L. (2009) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2009.01.002 · Cited by 12
Diverse influences on tau aggregation and implications for disease progressionPreprint
Alstyne, M. V., Pratt, J., & Parker, R. (2025) · Genes & Development · doi:10.1101/gad.352551.124 · Cited by 11
The interactome of tau phosphorylated at T217 in Alzheimer’s disease human brain tissue
Kavanagh, T., Thierry, M., Balcomb, K., Ponce, J., Kanshin, E., Tapia-Sealey, A., Halliday, G. M., Ueberheide, B. M., Wısnıewskı, T., & Drummond, E. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02881-8 · Cited by 11
Tian, S., Liu, Y., Hong, H., & Li, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05280-y · Cited by 8
Cho, Y., & Kim, Y. K. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01615-w · Cited by 8
Shi, C., Huang, X., Zhang, B., Zhu, D., Luo, H., Lu, Q., Xiong, W., Mei, L., & Luo, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138936 · Cited by 8
Hypothermia as a risk factor for Alzheimer disease
Almeida, M. C., & Carrettiero, D. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00044-6 · Cited by 8
Yurasakpong, L., Nantasenamat, C., Nobsathian, S., Chaithirayanon, K., & Apisawetakan, S. (2021) · Molecules · doi:10.3390/molecules26216377 · Cited by 8
Hyperthermia promotes degradation of the acute promyelocytic leukemia driver oncoprotein ZBTB16/RARα
Wang, Q., Hussain, L., Yu, P. H., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01001-6 · Cited by 8
Ubiquitin E3 ligases controlling p53 stability
Lee, S. W., Seong, M. W., Jeon, Y. J., & Chung, C. H. (2012) · Animal Cells and Systems · doi:10.1080/19768354.2012.688769 · Cited by 9
A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0519-7 · Cited by 8
Genetics of Parkinson's Disease
Huang, Y. M., Chan, P., & Halliday, G. M. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50169-1 · Cited by 10
Lei, H., Chen, X., Ruan, L., Liu, X., Ye, F., Li, K., Cheng, W., Yu, B., Di, C., & Di, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102927 · Cited by 7
Zayed, M., Kim, Y., & Jeong, B. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1411529 · Cited by 7
Liu, Y., Sun, Y., Huang, Y., Cheng, K., Xu, Y., Tian, Q., & Zhang, S. (2021) · Cell Death Discovery · doi:10.1038/s41420-020-00394-9 · Cited by 8
Ayoub, C. A., Wagner, C. S., & Kuret, J. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010681 · Cited by 8
Judelson, H. S., Ah‐Fong, A. M. V., & Fabritius, A. (2010) · Microbiology · doi:10.1099/mic.0.039305-0 · Cited by 7
Small Heat Shock Proteins and the Cytoskeleton
Richter‐Landsberg, C., & Goldbaum, O. (2009) · Springer eBooks · doi:10.1007/978-0-387-39954-6_2 · Cited by 7
The Functions of HSP70 in Normal Cells
Malyshev, I. Y. (2013) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-94-007-5943-5_2 · Cited by 7
Inhibition of tau aggregation by the CCT3 and CCT7 apical domains
Ben‐Maimon, M., Elad, N., Naveh‐Tassa, S., Levy, Y., & Horovitz, A. (2025) · Protein Science · doi:10.1002/pro.70162 · Cited by 7
Stable ubiquitin conjugation for biological interrogation of ubiquitinated tau repeat domain
Viola, G., Trivellato, D., Meulli, L., Tira, R., Lauriola, A., Munari, F., Montagnana, M., Buffelli, M., Assfalg, M., & D’Onofrio, M. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107549 · Cited by 6
Untangling the Complexity and Impact of Tau Protein Ubiquitination
Trivellato, D., Munari, F., Assfalg, M., Capaldi, S., & D’Onofrio, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400566 · Cited by 6
Navarro, P., Guerrero, R., Gallego, E., Ávila, J., Luquín, M. R., Ruiz, P., & Sánchez, M. P. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.013 · Cited by 6
Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7
Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation
Reinhardt, L., Musacchio, F., Bichmann, M., Behrendt, A., Ercan-Herbst, E., Stein, J., Becher, I., Haberkant, P., Mader, J. K., Schöndorf, D. C., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106126 · Cited by 6
Yakout, D. W., Shroff, A., Wei, W., Thaker, V. S., Allen, Z. D., Sajish, M., Nazarko, T. Y., & Mabb, A. M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107237 · Cited by 8
Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
Pace, M. C., Xu, G. M., Fromholt, S., Howard, J. C., Giasson, B. I., Lewis, J. M., & Borchelt, D. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0253-9 · Cited by 7
Kurepa, J., Wang, S., & Smalle, J. (2012) · Plant Signaling & Behavior · doi:10.4161/psb.21543 · Cited by 6
Babizhayev, M. A., Nikolayev, G. M., Nikolayeva, J. G., & Yegorov, Y. E. (2010) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2010.00601.x · Cited by 6
Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
Jia, Y.-J., Ge, Y., Li, B., Yang, Y., Chen, H., Liu, J., Guo, J., Yu, J., Ye, K., Wang, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2991-7 · Cited by 6
Lu, X., Pan, B.-L., Gao, D., Ju, X. F., 宦佳平, Han, X., Lu, X., & Wang, L. (2023) · Toxicology · doi:10.1016/j.tox.2023.153610 · Cited by 6
Insights into Dysregulated Neurological Biomarkers in Cancer
Duranti, E., & Villa, C. (2024) · Cancers · doi:10.3390/cancers16152680 · Cited by 7
Bhattacharjee, P., Roy, J., & Mandal, A. K. (2025) · Journal of Biosciences · doi:10.1007/s12038-025-00506-6 · Cited by 7
Inhibition of apoptosis via CHIP‐mediated proteasomal degradation of TAp73α
Tanwar, K., & Pati, U. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28386 · Cited by 5
Inhibitor Combinations Reveal Wiring of the Proteostasis Network in Prostate Cancer Cells
Shkedi, A., Adkisson, M., Schroeder, A., Eckalbar, W. L., Kuo, S.-Y., Neckers, L. Μ., & Gestwicki, J. E. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01342 · Cited by 5
Wauters, E., Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00009-9 · Cited by 6
Tang, P.-C., & Watson, G. M. (2015) · Hearing Research · doi:10.1016/j.heares.2015.07.005 · Cited by 5
Small molecule-mediated therapeutic approaches to target Tau and Alzheimer’s disease
Chinnathambi, S. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.11.010 · Cited by 4
Mechanistic insights of molecular chaperone Hsp70: Pathogenesis of neurodegenerative diseases
Choudhary, A., Kumar, P., Jagtap, Y. A., Kinger, S., Jha, H. C., Gutti, R. K., Sharma, V., Prajapati, V. K., & Mishra, A. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.05.001 · Cited by 5
Deubiquitinating Enzymes Ubiquitin-Specific Proteases 7 and 10 Regulate TAU Aggregation
Volbracht, C., & Fog, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211062 · Cited by 4
Targeted tau protein degradation: a promising therapeutic approach for tauopathies
Baazaoui, N., Alfaifi, M. Y., Shati, A. A., Saad, R. B., & Garzoli, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.041 · Cited by 5
Role of Ubiquitin Protein Ligases in the Pathogenesis of Polyglutamine Diseases
Dikshit, P., & Jana, N. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9459-x · Cited by 4
Smad ubiquitination regulatory factor-2 in progressive supranuclear palsy
Nakamura, M., Ito, H., Nakamura, Y., Wate, R., Kaneko, S., Nakano, S., Matsumoto, S.-I., & Kusaka, H. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01120.x · Cited by 4
Li, X., He, Z., Wang, C., Liu, Y., Shan, Z., Zhang, L., Shi, Q., Yue, C., Lin, Y., Liu, Y., et al. (2020) · Natural Product Communications · doi:10.1177/1934578x20948986 · Cited by 4
Tian, T. M., McLean, J. W., Wilson, J. A., & Wilson, S. M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15180 · Cited by 4
Chi, H., Sang, T., & Chang, H.-Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73198 · Cited by 5
Chaudhary, N., & Nagaraj, R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_4 · Cited by 4
Munari, F., Barracchia, C. G., Franchin, C., Parolini, F., Capaldi, S., Romeo, A., Bubacco, L., Assfalg, M., Arrigoni, G., & D’Onofrio, M. (2020) · Angewandte Chemie · doi:10.1002/ange.201916756 · Cited by 4
Molecular Chaperones in Neurodegeneration
Pandey, M., Nabi, J., Tabassum, N., Pottoo, F. H., Khatik, R., & Ahmad, N. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch014 · Cited by 4
Malyshev, I. Y. (2013) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-94-007-5943-5_8 · Cited by 4
STUB1-VCP/p97 complex regulates mitophagy via fine-tuning of PINK1 levels
Lin, J.-Y., Huang, Z.-B., Zhang, S.-Q., Wu, Y., Cheng, L.-J., Gao, X., Lautrup, S., Cao, S., Pan, J., Rong, D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117183 · Cited by 5
Stimulation of Tau Degradation
Quintanilla, R. A., Cabezas-Opazo, F., Pallo, S. P., Chesser, A. S., & Johnson, G. V. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00013-7 · Cited by 3
Molecular Pathways in Alzheimer’s Disease and Cognitive Function
Chen, X., Reichert, M. C., & Gan, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00005-x · Cited by 3
Structural Basis for Chaperone‐Independent Ubiquitination of Tau Protein by Its E3 Ligase CHIP
Munari, F., Mollica, L., Valente, C., Parolini, F., Kachoie, E. A., Arrigoni, G., D’Onofrio, M., Capaldi, S., & Assfalg, M. (2022) · Angewandte Chemie · doi:10.1002/ange.202112374 · Cited by 3
Protein Quality Control in Neurodegeneration and Neuroprotection
Akhter, Y., Nabi, J., Hamid, H., Tabassum, N., Pottoo, F. H., & Sharma, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch001 · Cited by 3
Bartolo, N. D., Mortimer, N., Manter, M. A., Sanchez, N., Riley, M. M., O’Malley, T. T., & Hooker, J. M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00607 · Cited by 3
cDNA Clones and Expression Analysis of cpHSC70 and mtHSC70 in Non-Heading Chinese Cabbage
Song, H., Song, X., Liu, H., et al. (2013) · Plant Molecular Biology Reporter · doi:10.1007/s11105-013-0659-z · Cited by 3
HSP70 interacting protein prevents the accumulation of inclusions in polyglutamine disease1
Howarth, J. L., Glover, C. P. J., & Uney, J. B. (2009) · Journal of Neurochemistry · doi:10.1111/j.0022-3042.2008.05847.x · Cited by 3
Tashiro, E., Kitagawa, M., & Imoto, M. (2017) · Springer eBooks · doi:10.1007/978-4-431-56529-1_4 · Cited by 3
Dickey, C. A., & Petrucelli, L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.09.001 · Cited by 3
Self-citationUbiquitin-Proteasome System Dysregulation in Alzheimer’s Disease Impacts Protein AbundancePreprint
Collins, M. A., Friedrich, C., Elcheikhali, M., Stewart, P., Derks, J., Connors, T. R., Altig, K., Melloni, A. N., Petelski, A. A., Oakley, D. H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656728 · Cited by 5
Dickson, D. W. (2007) · Blue Books of Neurology · doi:10.1016/s1877-184x(09)70058-9 · Cited by 3
SUMO inhibits Tau aggregation in Alzheimer’s disease
Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.02.001 · Cited by 4
Metadata
- Authors
- Petrucelli, L.
- Affiliations
- Mayo Clinic in Florida (US)
- Corresponding author
- Petrucelli, L.
- ORCID
- Petrucelli, L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-28
- Volume
- 13
- Issue
- 7
- Pages
- 703-714
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2168079270
- Cited by
- 723
- References
- 41
- Citations by year
- 2026: 29 · 2025: 36 · 2024: 32 · 2023: 32 · 2022: 37 · 2021: 37 · 2020: 36 · 2019: 25 · 2018: 35 · 2017: 31 · 2016: 31 · 2015: 38 · 2014: 34 · 2013: 28 · 2012: 31
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS041816, R01-NS41816-01)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- CHIP, HSP70, tau protein, ubiquitination, protein degradation, tau aggregation, molecular chaperones, ubiquitin ligase, geldanamycin, heat shock factor 1, tauopathy, Alzheimer's disease, Parkinson's disease, proteasome
- MeSH terms
- Heat Shock Transcription Factors, Animals, Cell Line, Detergents, DNA-Binding Proteins, Genetic Vectors, Humans, Immunohistochemistry, Lac Operon, Models, Genetic, Mutation, Nuclear Proteins, Protein Binding, Quinones, Subcellular Fractions, Transcription Factors, Transfection, Blotting, Western, Benzoquinones, tau Proteins, Molecular Chaperones, HSP70 Heat-Shock Proteins, Transgenes, COS Cells, Ubiquitin, Drosophila Proteins, Ubiquitin-Protein Ligases, Cell Line, Tumor, Lactams, Macrocyclic, Immunoprecipitation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review